Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: fluvastatin sodium|PROCEDURE: Breast Cancer Surgery Only - Arm III
Sponsor: University of California, San Francisco
Collaborators: National Cancer Institute (NCI)